Intellia Therapeutics Inc.

In News

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 - Investing News Network

Investing News Network - Feb 14, 2026

Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN - Intellia Therapeutics

Intellia Therapeutics - Jan 27, 2026

Is Intellia Therapeutics Inc. a top pick in the sector - Quarterly Profit Report & Advanced Swing Trade Entry Plans - mfd.ru

mfd.ru - Feb 14, 2026

A Look At Intellia Therapeutics (NTLA) Valuation After FDA Lifts Clinical Hold On Key Phase 3 Trial - Sahm

Sahm - Feb 09, 2026

Baird Updates Intellia Therapeutics, Inc. (NTLA)’s Financial Model Following Nex-Z Clinical Hold Removal - Yahoo Finance

Yahoo Finance - Feb 02, 2026

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Hold" by Analysts - MarketBeat

MarketBeat - Feb 09, 2026

Intellia Therapeutics to resume dosing of gene therapy in Phase III trial - Clinical Trials Arena

Clinical Trials Arena - Jan 28, 2026

FDA Lifts Clinical Hold on Intellia’s Trial for Gene Editing Therapy Nex-Z in ATTRv-PN, Places Holds on REGENXBIO MPS Trials - NeurologyLive

NeurologyLive - Jan 28, 2026

Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN - Stock Titan

Stock Titan - Jan 27, 2026

Intellia Therapeutics: 2 Major Catalysts Will Determine Stock Trajectory In 2026 (NTLA) - Seeking Alpha

Seeking Alpha - Feb 05, 2026

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates - Intellia Therapeutics

Intellia Therapeutics - Nov 06, 2025

Intellia Therapeutics, Inc. (NTLA): A Bear Case Theory - Yahoo Finance

Yahoo Finance - Dec 04, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment